Large-scale testing (Phase 3)Study completedNCT03319732
What this trial is testing
Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS
Who this might be right for
Multiple SclerosisSpasticity, Muscle
RVL Pharmaceuticals, Inc. 323